language |
eng
|
Author |
Zheng Guoqiao
1Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg D-69120, Germany. 2Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg D-69120, Germany. 3Faculty of Medicine, University of Heidelberg, Heidelberg, Germany.
Sundquist Kristina
Center for Primary Health Care Research, Lund University, Malmö 205 02, Sweden. 5Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 6Center for Community-Based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Izumo, Japan.
Sundquist Jan
Center for Primary Health Care Research, Lund University, Malmö 205 02, Sweden. 5Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 6Center for Community-Based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Izumo, Japan.
Foersti Asta
Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg D-69120, Germany. / Center for Primary Health Care Research, Lund University, Malmö 205 02, Sweden. / Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany. / Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
Hemminki Akseli
Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland. / Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.
Hemminki Kari
Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg D-69120, Germany. / Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg D-69120, Germany. / Center for Primary Health Care Research, Lund University, Malmö 205 02, Sweden. / Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Pilsen 30605, Czech Republic.
|
Subject | skin cancer; second cancer; first primary cancer; immune disturbance
|
Journal Title |
CLINICAL EPIDEMIOLOGY
|
Volume | 12
|
Start Page | 857
|
End Page | 864
|
ISSN | 1179-1349
|
Published Date | 2020
|
DOI | |
PubMed ID | |
Publisher | DOVE MEDICAL PRESS LTD
|
NII Type |
Journal Article
|
OAI-PMH Set |
Faculty of Medicine
|
Remark | We thank Patrick Reilly for excellent language editing. This study was supported by the European Union's Horizon 2020 research and innovation programme, grant No 856620, Jane and Aatos Erkko Foundation, HUCH Research Funds (EVO), Sigrid Juselius Foundation, Finnish Cancer Organizations, University of Helsinki, The Finnish Society of Sciences and Letters, and from the Swedish Research Council (2016-01176 and 2018-02400).
|